Buffalo, New York--(Newsfile Corp. - November 21, 2022) - GVB Biopharma, a 22nd Century Group company (NASDAQ: XXII), today announced that a fire occurred at its GVB Biopharma distillate and ...

GVB Biopharma has Achieved Strong Growth and Leading Market Share in Hemp-Derived Active Ingredients BUFFALO, N.Y., May 13, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a ...

Hotel occupancy taxes dropped by 26% in fiscal 2024, compared to 2019, which reduced the funds in the Tourist Attraction Fund where GVB gets most of its funding. GVB data shows hotel occupancy ...

GVB Biopharma, a 22nd Century Group company XXII has opened a new, strategically-located distribution facility in the Netherlands to support its growing business in Europe, the Middle East, and ...